Back to Search
Start Over
Highly sensitive near-infrared fluorescent probe for monitoring peroxynitrite in nonalcoholic fatty liver disease: Toward early diagnosis and therapeutic evaluation.
- Source :
-
Talanta [Talanta] 2025 Jan 01; Vol. 281, pp. 126865. Date of Electronic Publication: 2024 Sep 11. - Publication Year :
- 2025
-
Abstract
- Nonalcoholic fatty liver disease (NAFLD) poses a significant global health concern, necessitating precise diagnostic tools and effective treatment strategies. Peroxynitrite (ONOO <superscript>-</superscript> ), a reactive oxygen species, plays a pivotal role in NAFLD pathogenesis, highlighting its potential as a biomarker for disease diagnosis and therapeutic evaluation. This study reports on the development of a near-infrared (NIR) fluorescent probe, designated DRP-O, for the selective detection of ONOO <superscript>-</superscript> with high sensitivity and photostability. DRP-O exhibits rapid response kinetics (within 2 min) and an impressive detection limit of 2.3 nM, enabling real-time monitoring of ONOO <superscript>-</superscript> dynamics in living cells. Notably, DRP-O demonstrates excellent photostability under continuous laser irradiation, ensuring reliable long-term monitoring in complex biological systems. We apply DRP-O to visualize endogenous ONOO <superscript>-</superscript> in living cells, demonstrating its potential for diagnosing and monitoring NAFLD-related oxidative stress. Furthermore, DRP-O effectively evaluates the efficacy of therapeutic drugs in NAFLD cell models, underscoring its potential utility in drug screening studies. Moreover, we confirm DRP-O to enable selective identification of fatty liver tissues in a mouse model of NAFLD, indicating its potential for the early diagnosis of NAFLD. Collectively, DRP-O represents a valuable tool for studying ONOO <superscript>-</superscript> dynamics, evaluating drug efficacy, and diagnosing NAFLD, offering insights into novel therapeutic strategies for this prevalent liver disorder.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024. Published by Elsevier B.V.)
- Subjects :
- Animals
Humans
Mice
Early Diagnosis
Infrared Rays
Hep G2 Cells
Mice, Inbred C57BL
Optical Imaging
Non-alcoholic Fatty Liver Disease diagnostic imaging
Non-alcoholic Fatty Liver Disease drug therapy
Peroxynitrous Acid analysis
Peroxynitrous Acid metabolism
Fluorescent Dyes chemistry
Fluorescent Dyes chemical synthesis
Subjects
Details
- Language :
- English
- ISSN :
- 1873-3573
- Volume :
- 281
- Database :
- MEDLINE
- Journal :
- Talanta
- Publication Type :
- Academic Journal
- Accession number :
- 39265422
- Full Text :
- https://doi.org/10.1016/j.talanta.2024.126865